English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, September 15, 2021
Hua and Sinopharm Announced Supply Chain Strategic Cooperation
Thursday, August 19, 2021
华领医药公布2021年中期业绩
華領醫藥公佈2021年中期業績
Hua Medicine Announces 2021 Interim Results
Friday, April 23, 2021
华领医药糖尿病首创新药多扎格列艾汀NDA获NMPA受理!为全球首个葡萄糖激酶激活剂
華領醫藥糖尿病首創新藥多扎格列艾汀NDA獲NMPA受理!為全球首個葡萄糖激酶激活劑
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally
Friday, March 19, 2021
华领医药公布2020年全年业绩
華領醫藥公佈2020年全年業績
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine's Dorzagliatin Readying for NDA Submission

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575